{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:05:52Z","timestamp":1792292752306,"version":"4.4.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T00:00:00Z","timestamp":1615593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T00:00:00Z","timestamp":1615593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Medtronic International Trading Sarl"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s12325-021-01650-9","type":"journal-article","created":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T04:05:48Z","timestamp":1615608348000},"page":"1987-2006","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":91,"title":["Systematic Literature Review and Meta-Analysis of Sacral Neuromodulation (SNM) in Patients with Neurogenic Lower Urinary Tract Dysfunction (nLUTD): Over 20\u00a0Years\u2019 Experience and Future Directions"],"prefix":"10.1007","volume":"38","author":[{"given":"Arndt","family":"van Ophoven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Engelberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Lilley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Dietrich","family":"Sievert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,13]]},"reference":[{"key":"1650_CR1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.urology.2016.06.004","volume":"99","author":"D Liberman","year":"2017","unstructured":"Liberman D, Ehlert MJ, Siegel SW. Sacral neuromodulation in urological practice. Urology. 2017;99:14\u201322.","journal-title":"Urology"},{"issue":"2","key":"1650_CR2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0022-5347(05)68558-8","volume":"162","author":"RA Schmidt","year":"1999","unstructured":"Schmidt RA, Jonas U, Oleson KA, et al. Sacral nerve stimulation for treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study Group. J Urol. 1999;162(2):352\u20137.","journal-title":"J Urol"},{"issue":"6","key":"1650_CR3","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0022-5347(05)67558-1","volume":"163","author":"MM Hassouna","year":"2000","unstructured":"Hassouna MM, Siegel SW, N\u00ffeholt AA, et al. Sacral neuromodulation in the treatment of urgency-frequency symptoms: a multicenter study on efficacy and safety. J Urol. 2000;163(6):1849\u201354.","journal-title":"J Urol"},{"issue":"1","key":"1650_CR4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00005392-200101000-00004","volume":"165","author":"U Jonas","year":"2001","unstructured":"Jonas U, Fowler CJ, Chancellor MB, et al. Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation. J Urol. 2001;165(1):15\u20139.","journal-title":"J Urol"},{"issue":"4","key":"1650_CR5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5489\/cuaj.6499","volume":"14","author":"JB Gajewski","year":"2020","unstructured":"Gajewski JB, Hassouna MM, Corcos J, Gray GJ, Tu LM, Dwyer N. The history of sacral neuromodulation in Canada. Can Urol Assoc J. 2020;14(4):87\u201390.","journal-title":"Can Urol Assoc J"},{"issue":"2 Pt 1","key":"1650_CR6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0022-5347(17)38751-7","volume":"142","author":"EA Tanagho","year":"1989","unstructured":"Tanagho EA, Schmidt RA, Orvis BR. Neural stimulation for control of voiding dysfunction: a preliminary report in 22 patients with serious neuropathic voiding disorders. J Urol. 1989;142(2 Pt 1):340\u20135.","journal-title":"J Urol"},{"issue":"3","key":"1650_CR7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ucl.2017.04.005","volume":"44","author":"S Agrawal","year":"2017","unstructured":"Agrawal S, Agrawal RR, Wood HM. Establishing a multidisciplinary approach to the management of neurologic disease affecting the urinary tract. Urol Clin North Am. 2017;44(3):377\u201389.","journal-title":"Urol Clin North Am"},{"issue":"3","key":"1650_CR8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s42399-018-0005-8","volume":"1","author":"U Mehnert","year":"2018","unstructured":"Mehnert U, Chartier-Kastler E, de Wachter S, van Kerrebroeck P, van Koeveringe G. The management of urine storage dysfunction in the neurological patient. SN Compr Clin Med. 2018;1(3):160\u201382.","journal-title":"SN Compr Clin Med"},{"issue":"1","key":"1650_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12894-017-0216-4","volume":"17","author":"MJ Tijnagel","year":"2017","unstructured":"Tijnagel MJ, Scheepe JR, Blok BF. Real life persistence rate with antimuscarinic treatment in patients with idiopathic or neurogenic overactive bladder: a prospective cohort study with solifenacin. BMC Urol. 2017;17(1):30. https:\/\/doi.org\/10.1186\/s12894-017-0216-4.","journal-title":"BMC Urol"},{"issue":"1","key":"1650_CR10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/nau.24172","volume":"39","author":"DP Patel","year":"2020","unstructured":"Patel DP, Herrick JS, Stoffel JT, et al. Reasons for cessation of clean intermittent catheterization after spinal cord injury: results from the Neurogenic Bladder Research Group spinal cord injury registry. Neurourol Urodyn. 2020;39(1):211\u20139.","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"1650_CR11","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.eururo.2016.03.052","volume":"70","author":"L Leitner","year":"2016","unstructured":"Leitner L, Guggenb\u00fchl-Roy S, Kn\u00fcpfer SC, et al. More than 15 years of experience with intradetrusor onabotulinumtoxinA injections for treating refractory neurogenic detrusor overactivity: lessons to be learned. Eur Urol. 2016;70(3):522\u20138.","journal-title":"Eur Urol"},{"issue":"6","key":"1650_CR12","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.eururo.2010.09.024","volume":"58","author":"TM Kessler","year":"2010","unstructured":"Kessler TM, La Framboise D, Trelle S, et al. Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysis. Eur Urol. 2010;58(6):865\u201374.","journal-title":"Eur Urol"},{"key":"1650_CR13","unstructured":"EAU Guidelines 2020. https:\/\/uroweb.org\/guideline\/neurourology\/#3. Accessed 25 Aug 2020."},{"issue":"2","key":"1650_CR14","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s12325-019-01205-z","volume":"37","author":"S De Wachter","year":"2020","unstructured":"De Wachter S, Knowles CH, Elterman DS, et al. New technologies and applications in sacral neuromodulation: an update. Adv Ther. 2020;37(2):637\u201343.","journal-title":"Adv Ther"},{"issue":"11","key":"1650_CR15","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s004150050508","volume":"246","author":"A Hennessey","year":"1999","unstructured":"Hennessey A, Robertson NP, Swingler R, Compston DA. Urinary, faecal and sexual dysfunction in patients with multiple sclerosis. J Neurol. 1999;246(11):1027\u201332.","journal-title":"J Neurol"},{"issue":"3","key":"1650_CR16","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3174\/ajnr.A4539","volume":"37","author":"A Traboulsee","year":"2016","unstructured":"Traboulsee A, Simon JH, Stone L, et al. Revised recommendations of the consortium of MS centers task force for a standardized MRI protocol and clinical guidelines for the diagnosis and follow-up of multiple sclerosis. AJNR Am J Neuroradiol. 2016;37(3):394\u2013401.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6","key":"1650_CR17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/1756285617708911","volume":"10","author":"UW Kaunzner","year":"2017","unstructured":"Kaunzner UW, Gauthier SA. MRI in the assessment and monitoring of multiple sclerosis: an update on best practice. Ther Adv Neurol Disord. 2017;10(6):247\u201361.","journal-title":"Ther Adv Neurol Disord"},{"issue":"2","key":"1650_CR18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0720-048X(02)00046-3","volume":"42","author":"R Bodley","year":"2002","unstructured":"Bodley R. Imaging in chronic spinal cord injury\u2013indications and benefits. Eur J Radiol. 2002;42(2):135\u201353.","journal-title":"Eur J Radiol"},{"issue":"6","key":"1650_CR19","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/sj.sc.3101991","volume":"45","author":"MC Pagliacci","year":"2007","unstructured":"Pagliacci MC, Franceschini M, Di Clemente B, Agosti M, Spizzichino L, GISEM. A multicentre follow-up of clinical aspects of traumatic spinal cord injury. Spinal Cord. 2007;45(6):404\u201310.","journal-title":"Spinal Cord"},{"issue":"4","key":"1650_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"1","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;1(4):1.","journal-title":"Syst Rev"},{"key":"1650_CR21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00192-009-1023-6","volume":"21","author":"SP Marinkovic","year":"2010","unstructured":"Marinkovic SP, Gillen LM. Sacral neuromodulation for multiple sclerosis patients with urinary retention and clean intermittent catheterization. Int Urogynecol J. 2010;21:223\u20138.","journal-title":"Int Urogynecol J"},{"key":"1650_CR22","unstructured":"Howick J, Chalmers I, Glasziou P, et al. The Oxford 2011 levels of evidence. 2011. https:\/\/www.cebm.ox.ac.uk\/resources\/levels-of-evidence\/ocebm-levels-ofevidence. Accessed 25 Aug 2020."},{"issue":"355","key":"1650_CR23","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"12","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;12(355):i4919. https:\/\/doi.org\/10.1136\/bmj.i4919.","journal-title":"BMJ"},{"key":"1650_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1411]","author":"LA McGuinness","year":"2020","unstructured":"McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Syn Meth. 2020. https:\/\/doi.org\/10.1002\/jrsm.1411].","journal-title":"Res Syn Meth"},{"key":"1650_CR25","unstructured":"R Core Team. R: A language and environment for statistical computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing; 2019. https:\/\/www.r-project.org\/."},{"key":"1650_CR26","first-page":"177","volume":"9","author":"R Carone","year":"1999","unstructured":"Carone R, Bertapelle P, Zanollo A, et al. Sacral neuromodulation in neurogenic lower urinary tract dysfunctions: results of a multicenter study group. Urodinamica. 1999;9:177\u201382.","journal-title":"Urodinamica"},{"key":"1650_CR27","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1525-1403.2005.05236.x","volume":"8","author":"D Minardi","year":"2005","unstructured":"Minardi D, Muzzonigro G. Lower urinary tract and bowel disorders and multiple sclerosis: role of sacral neuromodulation: a preliminary report. Neuromodulation. 2005;8:176\u201381.","journal-title":"Neuromodulation"},{"issue":"8","key":"1650_CR28","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1111\/j.1463-1318.2011.02650.x","volume":"13","author":"TC Dudding","year":"2011","unstructured":"Dudding TC, Hollingshead JR, Nicholls RJ, Vaizey CJ. Sacral nerve stimulation for faecal incontinence: patient selection, service provision and operative technique. Colorectal Dis. 2011;13(8):e187\u201395.","journal-title":"Colorectal Dis"},{"key":"1650_CR29","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0090-4295(01)01412-1","volume":"58","author":"M Hohenfellner","year":"2001","unstructured":"Hohenfellner M, Humke J, Hampel C, et al. Chronic sacral neuromodulation for treatment of neurogenic bladder dysfunction: long-term results with unilateral implants. Urology. 2001;58:887\u201392.","journal-title":"Urology"},{"key":"1650_CR30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00345-002-0299-7","volume":"20","author":"B Schurch","year":"2003","unstructured":"Schurch B, Reilly I, Reitz A, Curt A. Electrophysiological recordings during the peripheral nerve evaluation (PNE) test in complete spinal cord injury patients. World J Urol. 2003;20:319\u201322.","journal-title":"World J Urol"},{"key":"1650_CR31","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/ana.21814","volume":"67","author":"K-D Sievert","year":"2010","unstructured":"Sievert K-D, Amend B, Gakis G, et al. Early sacral neuromodulation prevents urinary incontinence after complete spinal cord injury. Ann Neurol. 2010;67:74\u201384.","journal-title":"Ann Neurol"},{"key":"1650_CR32","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.aju.2018.05.006","volume":"16","author":"IS Al-Azzawi","year":"2018","unstructured":"Al-Azzawi IS, Al-Tamimi MAJ. The first Iraqi experience in sacral neuromodulation for patients with lower urinary tract dysfunction. Arab J Urol. 2018;16:391\u20136.","journal-title":"Arab J Urol"},{"key":"1650_CR33","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1100\/tsw.2011.13","volume":"11","author":"AM Arlen","year":"2011","unstructured":"Arlen AM, Powell CR, Kreder KJ. Sacral neuromodulation for refractory urge incontinence is less effective following spinal surgery. Sci World J. 2011;11:142\u20136.","journal-title":"Sci World J"},{"key":"1650_CR34","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/nau.21009","volume":"30","author":"W Chaabane","year":"2011","unstructured":"Chaabane W, Guillotreau J, Castel-lacanal E, et al. Sacral neuromodulation for treating neurogenic bladder dysfunction: clinical and urodynamic study. Neurourol Urodyn. 2011;30:547\u201350.","journal-title":"Neurourol Urodyn"},{"key":"1650_CR35","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/S0022-5347(05)67010-3","volume":"164","author":"EJ Chartier-Kastler","year":"2000","unstructured":"Chartier-Kastler EJ, Ruud Bosch JL, Perrigot M, Chancellor MB, Richard F, Denys P. Long-term results of sacral nerve stimulation (S3) for the treatment of neurogenic refractory urge incontinence related to detrusor hyperreflexia. J Urol. 2000;164:1476\u201380.","journal-title":"J Urol"},{"key":"1650_CR36","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/sc.2014.157","volume":"53","author":"G Chen","year":"2015","unstructured":"Chen G, Liao L. Sacral neuromodulation for neurogenic bladder and bowel dysfunction with multiple symptoms secondary to spinal cord disease. Spinal Cord. 2015;53:204\u20138.","journal-title":"Spinal Cord"},{"issue":"4","key":"1650_CR37","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/nau.20791","volume":"29","author":"DH Daniels","year":"2010","unstructured":"Daniels DH, Powell CR, Braasch MR, Kreder KJ. Sacral neuromodulation in diabetic patients: success and complications in the treatment of voiding dysfunction. Neurourol Urodyn. 2010;29(4):578\u201381.","journal-title":"Neurourol Urodyn"},{"key":"1650_CR38","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1525-1403.2012.00465.x","volume":"15","author":"S Denzinger","year":"2012","unstructured":"Denzinger S, Nowrotek A, Weingart P, et al. Does sacral neuromodulation lead to relevant reduction in the need for intermittent catheterization? A single-center experience on patients with chronic urinary retention. Neuromodulation Technol Neural Interface. 2012;15:586\u201391.","journal-title":"Neuromodulation Technol Neural Interface"},{"key":"1650_CR39","doi-asserted-by":"publisher","DOI":"10.1097\/SPV.0000000000000605","author":"AD Dobberfuhl","year":"2018","unstructured":"Dobberfuhl AD, Mahal A, Dallas KB, Choi KM, Comiter CV, Elliott CS. Statewide success of staged sacral neuromodulation for the treatment of urinary complaints in California (2005\u20132011). Female Pelvic Med Reconstr Surg. 2018. https:\/\/doi.org\/10.1097\/SPV.0000000000000605.","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"1650_CR40","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12894-015-0102-x","volume":"15","author":"DS Engeler","year":"2015","unstructured":"Engeler DS, Meyer D, Abt D, M\u00fcller S, Schmid H-P. Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series. BMC Urol. 2015;15:105. https:\/\/doi.org\/10.1186\/s12894-015-0102-x.","journal-title":"BMC Urol"},{"key":"1650_CR41","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1463-1318.2011.02678.x","volume":"14","author":"SMP Lansen-Koch","year":"2012","unstructured":"Lansen-Koch SMP, Govaert B, Oerlemans D, et al. Sacral nerve modulation for defaecation and micturition disorders in patients with spina bifida. Colorectal Dis. 2012;14:508\u201314.","journal-title":"Colorectal Dis"},{"key":"1650_CR42","first-page":"157","volume":"48","author":"A Lavano","year":"2004","unstructured":"Lavano A, Volpentesta G, Aloisi M, Veltri C, Piragine G, Signorelli CD. Use of chronic sacral nerve stimulation in neurological voiding disorders. J Neurosurg Sci. 2004;48:157\u20139.","journal-title":"J Neurosurg Sci"},{"key":"1650_CR43","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sc.2013.155","volume":"52","author":"G Lombardi","year":"2014","unstructured":"Lombardi G, Musco S, Celso M, Del Corso F, Del Popolo G. Sacral neuromodulation for neurogenic non-obstructive urinary retention in incomplete spinal cord patients: a ten-year follow-up single-centre experience. Spinal Cord. 2014;52:241\u20135.","journal-title":"Spinal Cord"},{"key":"1650_CR44","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00345-011-0669-0","volume":"30","author":"D Minardi","year":"2012","unstructured":"Minardi D, Muzzonigro G. Sacral neuromodulation in patients with multiple sclerosis. World J Urol. 2012;30:123\u20138.","journal-title":"World J Urol"},{"key":"1650_CR45","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.urology.2012.11.073","volume":"81","author":"KM Peters","year":"2013","unstructured":"Peters KM, Kandagatla P, Killinger KA, Wolfert C, Boura JA. Clinical outcomes of sacral neuromodulation in patients with neurologic conditions. Urology. 2013;81:738\u201344.","journal-title":"Urology"},{"key":"1650_CR46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1094-7159.2004.04018.x","volume":"7","author":"C Seif","year":"2004","unstructured":"Seif C, Eckermann J, Bross S, Portillo FJM, J\u00fcnemann K-P, Braun P-M. Findings with bilateral sacral neurostimulation: sixty-two PNE-tests in patients with neurogenic and idiopathic bladder dysfunctions. Neuromodulation. 2004;7:141\u20135.","journal-title":"Neuromodulation"},{"key":"1650_CR47","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1097\/01.ju.0000092634.64580.9a","volume":"170","author":"M Spinelli","year":"2003","unstructured":"Spinelli M, Giardiello G, Gerber M, Arduini A, van den Hombergh U, Malaguti S. New sacral neuromodulation lead for percutaneous implantation using local anesthesia: description and first experience. J Urol. 2003;170:1905\u20137.","journal-title":"J Urol"},{"key":"1650_CR48","doi-asserted-by":"crossref","first-page":"96.e1","DOI":"10.1016\/j.ajog.2007.04.016","volume":"197","author":"PA Wallace","year":"2007","unstructured":"Wallace PA, Lane FL, Noblett KL. Sacral nerve neuromodulation in patients with underlying neurologic disease. Am J Obstet Gynecol. 2007;197:96.e1-96.e5.","journal-title":"Am J Obstet Gynecol"},{"key":"1650_CR49","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/sc.2015.124","volume":"54","author":"J W\u00f6llner","year":"2016","unstructured":"W\u00f6llner J, Krebs J, Pannek J. Sacral neuromodulation in patients with neurogenic lower urinary tract dysfunction. Spinal Cord. 2016;54:137\u201340.","journal-title":"Spinal Cord"},{"issue":"6","key":"1650_CR50","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/ner.12902","volume":"22","author":"P Zhang","year":"2019","unstructured":"Zhang P, Wang JY, Zhang Y, et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: five-year experience of a retrospective, multicenter study in China. Neuromodulation. 2019;22(6):730\u20137.","journal-title":"Neuromodulation"},{"key":"1650_CR51","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.urology.2005.04.031","volume":"66","author":"CL Amundsen","year":"2005","unstructured":"Amundsen CL, Romero AA, Jamison MG, Webster GD. Sacral neuromodulation for intractable urge incontinence: are there factors associated with cure? Urology. 2005;66:746\u201350.","journal-title":"Urology"},{"key":"1650_CR52","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jns.2014.10.010","volume":"347","author":"E Andretta","year":"2014","unstructured":"Andretta E, Simeone C, Ostardo E, Pastorello M, Zuliani C. Usefulness of sacral nerve modulation in a series of multiple sclerosis patients with bladder dysfunction. J Neurol Sci. 2014;347:257\u201361.","journal-title":"J Neurol Sci"},{"issue":"1","key":"1650_CR53","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.juro.2008.03.054","volume":"180","author":"P Bertapelle","year":"2008","unstructured":"Bertapelle P, Bodo G, Carone R. Detrusor acontractility in urinary retention: detrusor contractility test as exclusion criteria for sacral neurostimulation. J Urol. 2008;180(1):215\u20136.","journal-title":"J Urol"},{"issue":"3 Pt 1","key":"1650_CR54","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0022-5347(01)62795-2","volume":"160","author":"M Hohenfellner","year":"1998","unstructured":"Hohenfellner M, Schultz-Lampel D, Dahms S, Matzel K, Th\u00fcroff JW. Bilateral chronic sacral neuromodulation for treatment of lower urinary tract dysfunction. J Urol. 1998;160(3 Pt 1):821\u20134.","journal-title":"J Urol"},{"issue":"2","key":"1650_CR55","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1464-410X.1998.00569.x","volume":"81","author":"M Ishigooka","year":"1998","unstructured":"Ishigooka M, Suzuki Y, Hashimoto T, Sasagawa I, Nakada T, Handa Y. A new technique for sacral nerve stimulation: a percutaneous method for urinary incontinence caused by spinal cord injury. Br J Urol. 1998;81(2):315\u20138.","journal-title":"Br J Urol"},{"issue":"12","key":"1650_CR56","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1007\/s00345-019-02721-x","volume":"37","author":"F Sharifiaghdas","year":"2019","unstructured":"Sharifiaghdas F. Sacral neuromodulation in congenital lumbo-sacral and traumatic spinal cord defects with neurogenic lower urinary tract symptoms: a single-center experience in children and adolescents. World J Urol. 2019;37(12):2775\u201383.","journal-title":"World J Urol"},{"issue":"1","key":"1650_CR57","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.juro.2017.07.010","volume":"199","author":"S Siegel","year":"2018","unstructured":"Siegel S, Noblett K, Mangel J, et al. Five-year followup results of a prospective, multicenter study of patients with overactive bladder treated with sacral neuromodulation. J Urol. 2018;199(1):229\u201336.","journal-title":"J Urol"},{"issue":"2","key":"1650_CR58","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/nau.22707","volume":"35","author":"K Noblett","year":"2016","unstructured":"Noblett K, Siegel S, Mangel J, et al. Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder. Neurourol Urodyn. 2016;35(2):246\u201351.","journal-title":"Neurourol Urodyn"},{"issue":"6","key":"1650_CR59","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/nau.23140","volume":"36","author":"JM Bartley","year":"2017","unstructured":"Bartley JM, Killinger KA, Boura J, et al. The impact of prior back surgery on neuromodulation outcomes: a review of over 500 patients. Neurourol Urodyn. 2017;36(6):1535\u201342.","journal-title":"Neurourol Urodyn"},{"key":"1650_CR60","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/sc.2008.172","volume":"47","author":"G Lombardi","year":"2009","unstructured":"Lombardi G, Del Popolo G. Clinical outcome of sacral neuromodulation in incomplete spinal cord injured patients suffering from neurogenic lower urinary tract symptoms. Spinal Cord. 2009;47:486\u201391.","journal-title":"Spinal Cord"},{"key":"1650_CR61","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2147\/JMDH.S160029","volume":"11","author":"VB Katkade","year":"2018","unstructured":"Katkade VB, Sanders KN, Zou KH. Real world data: an opportunity to supplement existing evidence for the use of long-established medicines in health care decision making. J Multidiscip Healthc. 2018;11:295\u2013304. https:\/\/doi.org\/10.2147\/JMDH.S160029.","journal-title":"J Multidiscip Healthc"},{"issue":"8","key":"1650_CR62","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/nau.23255","volume":"36","author":"DB Hennessey","year":"2017","unstructured":"Hennessey DB, Hoag N, Gani J. Sacral neuromodulation for detrusor hyperactivity with impaired contractility. Neurourol Urodyn. 2017;36(8):2117\u201322.","journal-title":"Neurourol Urodyn"},{"key":"1650_CR63","doi-asserted-by":"publisher","DOI":"10.1111\/ner.13117","author":"PA Lehur","year":"2020","unstructured":"Lehur PA, S\u00f8rensen M, Dudding TC, et al. Programming algorithms for sacral neuromodulation: clinical practice and evidence-recommendations for day-to-day practice. Neuromodulation. 2020. https:\/\/doi.org\/10.1111\/ner.13117.","journal-title":"Neuromodulation"},{"key":"1650_CR64","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.urology.2019.02.013","volume":"127","author":"A Manjunath","year":"2019","unstructured":"Manjunath A, Keeter MK, Koloms K, Kielb SJ. Abdominal versus standard placement of the sacral nerve stimulator implantable pulse generator. Urology. 2019;127:49\u201352.","journal-title":"Urology"},{"issue":"3 Pt 1","key":"1650_CR65","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0022-5347(05)00335-6","volume":"175","author":"J Groen","year":"2006","unstructured":"Groen J, Ruud Bosch JL, van Mastrigt R. Sacral neuromodulation in women with idiopathic detrusor overactivity incontinence: decreased overactivity but unchanged bladder contraction strength and urethral resistance during voiding. J Urol. 2006;175(3 Pt 1):1005\u20139.","journal-title":"J Urol"},{"issue":"3","key":"1650_CR66","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1464-410X.2007.07258.x","volume":"101","author":"PM Groenendijk","year":"2008","unstructured":"Groenendijk PM, Lycklama \u00e0 Nyeholt AA, Heesakkers JP, et al. Urodynamic evaluation of sacral neuromodulation for urge urinary incontinence. BJU Int. 2008;101(3):325\u20139.","journal-title":"BJU Int"},{"key":"1650_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2019.11.018","author":"S De Wachter","year":"2020","unstructured":"De Wachter S, Vaganee D, Kessler TM. Sacral neuromodulation: mechanism of action. Eur Urol Focus. 2020. https:\/\/doi.org\/10.1016\/j.euf.2019.11.018.","journal-title":"Eur Urol Focus"},{"issue":"4","key":"1650_CR68","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/sc.2012.164","volume":"51","author":"J Krebs","year":"2013","unstructured":"Krebs J, Pannek J. Effects of solifenacin in patients with neurogenic detrusor overactivity as a result of spinal cord lesion. Spinal Cord. 2013;51(4):306\u20139.","journal-title":"Spinal Cord"},{"issue":"1","key":"1650_CR69","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/nau.22395","volume":"33","author":"YC Chen","year":"2014","unstructured":"Chen YC, Kuo HC. The therapeutic effects of repeated detrusor injections between 200 or 300 units of onabotulinumtoxinA in chronic spinal cord injured patients. Neurourol Urodyn. 2014;33(1):129\u201334.","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"1650_CR70","doi-asserted-by":"publisher","first-page":"106","DOI":"10.5489\/cuaj.52","volume":"1","author":"MM Hassouna","year":"2007","unstructured":"Hassouna MM, Elkelini MS. Early versus late treatment of voiding dysfunction with pelvic neuromodulation. Can Urol Assoc J. 2007;1(2):106\u201310. https:\/\/doi.org\/10.5489\/cuaj.52.","journal-title":"Can Urol Assoc J"},{"issue":"S1","key":"1650_CR71","first-page":"S204","volume":"38","author":"D Greenberg","year":"2019","unstructured":"Greenberg D, Sohlberg E, Zhang C, Comiter CV, Enemchukwu E. Sacral neuromodulation in Parkinson\u2019s disease patients with neurogenic bladder. Neurourol Urodyn. 2019;38(S1):S204.","journal-title":"Neurourol Urodyn"},{"issue":"S1","key":"1650_CR72","first-page":"S126","volume":"38","author":"B Peyronnet","year":"2019","unstructured":"Peyronnet B, Biardeau X, Cornu JN, et al. Sacral neuromodulation in patients with Parkinson\u2019s disease: a multicenter study. Neurourol Urodyn. 2019;38(S1):S126.","journal-title":"Neurourol Urodyn"},{"issue":"6","key":"1650_CR73","doi-asserted-by":"crossref","first-page":"991","DOI":"10.23736\/S1973-9087.17.04978-4","volume":"53","author":"C Joussain","year":"2017","unstructured":"Joussain C, Ph\u00e9 V, Even A, Chartier-Kastler E, Denys P. Intradetrusor injection of botulinum toxin A and sacral neuromodulation for neurogenic detrusor overactivity. Eur J Phys Rehabil Med. 2017;53(6):991\u20137.","journal-title":"Eur J Phys Rehabil Med"},{"issue":"8","key":"1650_CR74","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/ner.12695","volume":"20","author":"KE Matzel","year":"2017","unstructured":"Matzel KE, Chartier-Kastler E, Knowles CH, et al. Sacral neuromodulation: standardized electrode placement technique. Neuromodulation. 2017;20(8):816\u201324.","journal-title":"Neuromodulation"},{"issue":"3","key":"1650_CR75","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.juro.2011.04.059","volume":"186","author":"J Groen","year":"2011","unstructured":"Groen J, Blok BF, Bosch JL. Sacral neuromodulation as treatment for refractory idiopathic urge urinary incontinence: 5-year results of a longitudinal study in 60 women. J Urol. 2011;186(3):954\u20139.","journal-title":"J Urol"},{"key":"1650_CR76","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1471-2490-14-65","volume":"14","author":"SC Kn\u00fcpfer","year":"2014","unstructured":"Kn\u00fcpfer SC, Liechti MD, Mordasini L, et al. Protocol for a randomized, placebo-controlled, double-blind clinical trial investigating sacral neuromodulation for neurogenic lower urinary tract dysfunction. BMC Urol. 2014;14:65.","journal-title":"BMC Urol"},{"issue":"353","key":"1650_CR77","doi-asserted-by":"publisher","first-page":"i2372","DOI":"10.1136\/bmj.i2372","volume":"9","author":"A Sedrakyan","year":"2016","unstructured":"Sedrakyan A, Campbell B, Merino JG, Kuntz R, Hirst A, McCulloch P. IDEAL-D: a rational framework for evaluating and regulating the use of medical devices. BMJ. 2016;9(353):i2372. https:\/\/doi.org\/10.1136\/bmj.i2372.","journal-title":"BMJ"},{"key":"1650_CR78","unstructured":"Spinelli M. The future of sacral nerve stimulation. Pelviperineology. 2007;26:17\u201318. http:\/\/cms.galenos.com.tr\/Uploads\/Article_37222\/Pelviperineology-26-17-En.pdf."}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01650-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-021-01650-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01650-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T05:46:32Z","timestamp":1671601592000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-021-01650-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,13]]},"references-count":78,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1650"],"URL":"https:\/\/doi.org\/10.1007\/s12325-021-01650-9","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,13]]},"assertion":[{"value":"16 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}